864 (Topiramate Extended-Release 50 mg)
Pill with imprint 864 is White, Capsule-shape and has been identified as Topiramate Extended-Release 50 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..
Topiramate is used in the treatment of epilepsy; seizure prevention; lennox-gastaut syndrome; migraine prevention; seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 864
- 50 mg
- 21.00 mm
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Zydus Pharmaceuticals (USA) Inc.
- Cadila Healthcare Limited
- National Drug Code (NDC)
- Inactive Ingredients
ethylcelluloses, isopropyl alcohol, hypromelloses, hydrogenated castor oil, microcrystalline cellulose, povidone, polyethylene glycol, magnesium silicate, triethyl citrate, gelatin, sodium lauryl sulfate, titanium dioxide, butyl alcohol, alcohol, ferrosoferric oxide, potassium hydroxide, propylene glycol, shellac, ammonia, water
Note: Inactive ingredients may vary.
Related Images for "864"
More about topiramate
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 1080 Reviews
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- FDA Alerts (3)
- Topiramate Extended-Release Sprinkle Capsules
- Topiramate Tablets
- Topiramate Extended-Release Capsules
- Topiramate Sprinkle Capsules
- Topiramate (Advanced Reading)
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.